Feline
Buspirone for Cats: Urine Spraying, Anxiety, and Off-Label Use in Feline Behavioral Medicine
Bottom line
Buspirone is an azapirone anxiolytic used entirely off-label in cats, and its best-supported feline indication is urine spraying/marking — with a marked advantage in multi-cat, socially stressed households [1]. It acts as a serotonin 5-HT1A partial agonist (with partial dopamine D2 activity), delivering anxiolysis without the sedation, ataxia, or physical dependence of benzodiazepines [2][3]. Onset is slow — roughly 1–4 weeks — so it is a maintenance drug for generalized, social, and fear-based anxiety, NOT a rescue for acute situational anxiety [3]. Use it as an adjunct to environmental and behavioral management, typically as a second-line or add-on option to the better-evidenced SSRIs and TCAs.
Drug facts
- Class: azapirone anxiolytic — chemically and mechanistically distinct from the benzodiazepines [3].
- Mechanism: partial agonist at pre- and postsynaptic serotonin 5-HT1A receptors with partial dopamine D2 receptor agonism [2][3]. It is anxioselective: minimal sedation and none of the anticonvulsant or muscle-relaxant activity of benzodiazepines. It does not produce physical dependence, even after months of continuous treatment [2].
- Formulations: human generic oral tablets (originally marketed as BuSpar); there is no veterinary-labeled buspirone product, so every feline use is extra-label [4]. Oral bioavailability is good, but transdermal absorption in cats is poor — compounded transdermal gels are unreliable and should be avoided [2].
- Regulatory status: no FDA veterinary approval and no labeled feline indication; prescribing rests on the veterinarian's extra-label clinical judgment [4].
Dosing in cats (off-label)
All feline dosing is extrapolated from small studies, formularies, and clinical experience — there is no label dose, so titrate to the individual patient.
- A commonly cited range is 0.5–1 mg/kg PO q12–24h, up to about 7.5 mg/cat q12h [2].
- Plumb's lists roughly 2.5–5 mg/cat PO q12h for anxiety and 2.5–7.5 mg/cat PO q12h for urine marking/spraying [4].
- Dose twice daily. Buspirone has a short half-life and must be given on a fixed daily schedule, not on an as-needed basis [2].
- Titrate and give it time. Clinical response typically takes 1–4 weeks (about 7–30 days) [3], with some sources citing 10–14 days [2]. Do not conclude failure before several weeks at an adequate twice-daily dose.
Efficacy evidence
The anchoring feline study is Hart, Eckstein, Powell, and Dodman (1993, JAVMA), an open trial of buspirone for urine spraying and inappropriate urination in cats [1]:
- Buspirone produced a favorable response (>75% reduction in spraying) in 55% of treated cats [1].
- Cats from multi-cat households responded significantly better than single-cat cats (P < 0.001) — fitting its role in social and territorial stress [1].
- There was no sex difference in effectiveness between male and female cats [1].
- Among cats with inappropriate urination (rather than spraying), 56% returned to normal litter box use [1].
- Relapse after discontinuation was far lower than with diazepam: when buspirone was withdrawn after two months, only about half of responders resumed marking, versus over 90% of cats after diazepam withdrawal (P < 0.001) [1].
Interpret this honestly. As of 2026, the feline evidence base for buspirone is older and limited — much of it rests on this single trial and on extrapolation from human pharmacology — and buspirone has generally shown no greater control of anxiety-related behaviors than the benzodiazepines [3]. Its real edge is the favorable relapse and safety profile, not superior raw efficacy [1][2].
Adverse effects
Buspirone is generally very well tolerated and non-sedating [3].
- Adverse effects are infrequent; mild gastrointestinal signs are the most likely, and sedation is only occasionally reported despite the anxioselective profile [2].
- Some cats show increased affection or friendliness on treatment.
- A clinically important behavioral caveat: because buspirone reduces fear and increases confidence, a previously timid or "victim" cat may become bolder and turn to confront the aggressor in a multi-cat conflict, shifting the household's social dynamics [2][5]. Anxiolytics can disinhibit fearful cats, and that new confidence can escalate into aggression — so direct buspirone at the fearful/target cat and use it cautiously wherever overt aggression already exists [5].
Contraindications and drug interactions
- Hepatic or renal impairment: buspirone is hepatically metabolized and renally cleared; use cautiously and consider a lower dose in cats with liver or kidney disease [4].
- MAO inhibitors — avoid: combining buspirone with an MAOI, including selegiline (L-deprenyl) and the topical acaricide amitraz, risks serotonin syndrome [2].
- Other serotonergic drugs: effects are additive with SSRIs, TCAs, tramadol, and similar agents — combine deliberately and monitor for serotonin syndrome [4].
- CYP3A4 inhibitors raise buspirone levels: buspirone is a CYP3A4 substrate, so azole antifungals (e.g., ketoconazole, itraconazole), macrolides (e.g., erythromycin, clarithromycin), and — in humans — grapefruit can substantially increase exposure; anticipate an exaggerated effect and reduce the dose accordingly [4].
- Additive CNS depression is possible with other centrally acting agents [4].
Where buspirone sits versus alternatives
Versus benzodiazepines (e.g., diazepam): buspirone avoids benzodiazepine sedation, ataxia, and behavioral disinhibition, and it causes no dependence [3]. Critically, it sidesteps the rare but frequently fatal idiosyncratic hepatic necrosis reported with oral diazepam in cats — a landmark case series described fulminant hepatic failure after repeated oral diazepam, with most affected cats dying [6]. The trade-off is buspirone's slower onset — weeks, versus the near-immediate effect of a benzodiazepine [3].
Versus SSRIs and TCAs: for feline urine marking, the SSRI fluoxetine and the TCA clomipramine generally carry stronger, broader evidence and are common first-line maintenance choices; buspirone is frequently a second-line or adjunct agent and can be used specifically to enhance the anxiolytic effect of an SSRI or TCA [3].
Versus situational agents: buspirone's slow onset makes it unsuitable for acute, event-based anxiety such as veterinary visits or travel — for those, reach for a situational protocol such as gabapentin or trazodone instead [3].
Frequently Asked Questions
What is the buspirone dose for cats? There is no label dose — use is off-label. Commonly cited regimens are 0.5–1 mg/kg PO q12–24h, up to about 7.5 mg/cat q12h [2], while Plumb's lists roughly 2.5–5 mg/cat q12h for anxiety and 2.5–7.5 mg/cat q12h for urine marking [4]. Give it twice daily on a fixed schedule and titrate to effect [3].
How long does buspirone take to work in cats? Roughly 1–4 weeks (about 7–30 days) [3], with some sources citing 10–14 days [2]. It is a maintenance drug given daily, not a fast-acting situational option, so do not judge it a failure before several weeks at an adequate dose [3].
Buspirone vs fluoxetine for cat spraying — which is better? Fluoxetine, an SSRI, generally has stronger, broader evidence for feline urine marking and is a common first-line maintenance choice; buspirone is usually second-line or an adjunct, and can be used to enhance an SSRI's anxiolytic effect [3]. Buspirone's documented advantage is a much lower relapse rate after discontinuation than diazepam, plus a clean, non-sedating safety profile [1].
Is buspirone safe long term in cats? It is generally well tolerated for chronic use and, unlike benzodiazepines, does not cause dependence even after months of treatment [2]. Adverse effects are infrequent, with mild GI signs most common [2]. Use caution and consider dose reduction in cats with hepatic or renal impairment [4].
Can buspirone be combined with an SSRI? Yes, and it is done deliberately — buspirone is used to augment SSRIs and TCAs [3]. Because both are serotonergic, combine at conservative doses and monitor for serotonin syndrome [4]. Avoid concurrent MAOIs, including selegiline and topical amitraz [2].
Can buspirone be used for vet visits or travel? No. Its onset is 1–4 weeks, so it does nothing for acute, event-based anxiety [3]. Use a situational protocol such as gabapentin or trazodone for previsit or travel anxiety instead.
Why choose buspirone over diazepam in cats? Buspirone avoids benzodiazepine sedation, ataxia, disinhibition, and dependence [3], and it sidesteps the rare but frequently fatal idiosyncratic hepatic necrosis reported with oral diazepam in cats [6]. It also showed a far lower relapse rate after discontinuation than diazepam — about half versus over 90% [1]. The trade-off is a slower onset [3].
Does buspirone cause sedation in cats? It is anxioselective and essentially non-sedating [3], which is a key advantage over benzodiazepines. Sedation is occasionally reported, but adverse effects overall are infrequent, with mild GI signs the most likely [2].
References
- Hart BL, Eckstein RA, Powell KL, Dodman NH. Effectiveness of buspirone on urine spraying and inappropriate urination in cats. J Am Vet Med Assoc. 1993;203(2):254-258. (1993)
- Denenberg S, Bräm Dubé M. Tools for managing feline problem behaviours: Psychoactive medications. J Feline Med Surg. 2018;20(11):1034-1045. (2018)
- Merck Veterinary Manual. Psychotropic Agents for Treatment of Animals (Systemic Pharmacotherapeutics of the Nervous System). (2022)
- Plumb DC. Plumb's Veterinary Drug Handbook, 10th ed. — Buspirone HCl. Wiley-Blackwell. (2023)
- Merck Veterinary Manual. Behavior Problems of Cats. (2022)
- Center SA, Elston TH, Rowland PH, et al. Fulminant hepatic failure associated with oral administration of diazepam in 11 cats. J Am Vet Med Assoc. 1996;209(3):618-625. (1996)
More clinical updates
Clomipramine (Clomicalm) for Dogs and Cats: Behavioral Dosing, Efficacy, and Safety
Clomipramine is a tricyclic antidepressant FDA-approved (Clomicalm) as an adjunct to behavior modification for canine separation anxiety, and used off-label for feline urine marking and canine/feline compulsive disorders. This hub covers species-specific dosing, the registration and compulsive-disorder RCTs, adverse effects, MAOI/serotonergic interactions, and where it sits versus fluoxetine, trazodone, and buspirone.
Read →Trazodone for Dogs: Situational Anxiety and Post-Op Confinement Dosing
A clinical reference for prescribing trazodone in dogs: SARI mechanism, off-label status, situational and post-operative confinement dosing, onset, adverse effects, and serotonin syndrome risk with concurrent SSRIs and MAOIs.
Read →Fluoxetine (Reconcile) for Canine Behavior Disorders
Clinical reference on fluoxetine (Reconcile/Prozac) for dogs: FDA-approved separation-anxiety indication, 1-2 mg/kg dosing, 4-6 week onset, adverse effects, and the MAOI/amitraz and serotonin-syndrome interactions every prescriber must screen for.
Read →Methylxanthine (Chocolate & Caffeine) Toxicosis in Dogs
ER reference for canine methylxanthine (chocolate/caffeine) toxicosis: theobromine/caffeine MOA and kinetics, mg/kg dose thresholds, chocolate-type ranking, decontamination, and symptomatic management of tachyarrhythmia, seizures, and hyperthermia.
Read →